Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 11 | 2026 | 544 | 2.990 |
Why?
|
| Immunotherapy | 6 | 2026 | 268 | 1.260 |
Why?
|
| Neoplasms | 5 | 2025 | 1376 | 1.030 |
Why?
|
| Immunity, Innate | 5 | 2024 | 828 | 0.960 |
Why?
|
| Cyclic GMP | 3 | 2022 | 33 | 0.950 |
Why?
|
| Neuroblastoma | 1 | 2026 | 55 | 0.950 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2025 | 351 | 0.940 |
Why?
|
| Cancer Vaccines | 1 | 2025 | 51 | 0.910 |
Why?
|
| Adjuvants, Immunologic | 1 | 2025 | 235 | 0.840 |
Why?
|
| Drug Delivery Systems | 4 | 2024 | 333 | 0.770 |
Why?
|
| Vaccination | 1 | 2025 | 373 | 0.760 |
Why?
|
| Antigen-Presenting Cells | 3 | 2021 | 179 | 0.660 |
Why?
|
| Gold | 4 | 2017 | 235 | 0.650 |
Why?
|
| Metal Nanoparticles | 4 | 2017 | 190 | 0.640 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 42 | 0.600 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 55 | 0.600 |
Why?
|
| Lipid A | 1 | 2019 | 67 | 0.600 |
Why?
|
| Nanocapsules | 1 | 2019 | 21 | 0.600 |
Why?
|
| Interferon-beta | 1 | 2019 | 79 | 0.590 |
Why?
|
| Lipid Bilayers | 2 | 2018 | 53 | 0.570 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 74 | 0.560 |
Why?
|
| Permeability | 1 | 2018 | 50 | 0.550 |
Why?
|
| Tumor Microenvironment | 5 | 2026 | 174 | 0.540 |
Why?
|
| Membrane Fusion | 1 | 2018 | 68 | 0.530 |
Why?
|
| Blood Vessels | 1 | 2016 | 63 | 0.480 |
Why?
|
| Molecular Imaging | 1 | 2016 | 53 | 0.480 |
Why?
|
| Glycocalyx | 1 | 2015 | 3 | 0.460 |
Why?
|
| Erythrocyte Membrane | 1 | 2015 | 25 | 0.460 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 177 | 0.460 |
Why?
|
| Mice | 11 | 2026 | 11132 | 0.410 |
Why?
|
| Animals | 13 | 2026 | 21408 | 0.400 |
Why?
|
| Immunologic Factors | 2 | 2022 | 109 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 3474 | 0.310 |
Why?
|
| Dendritic Cells | 5 | 2025 | 533 | 0.300 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 350 | 0.300 |
Why?
|
| Cell Line, Tumor | 3 | 2026 | 1566 | 0.250 |
Why?
|
| Drug Carriers | 3 | 2024 | 187 | 0.230 |
Why?
|
| Immunization | 2 | 2022 | 137 | 0.210 |
Why?
|
| Macrophages | 3 | 2025 | 1049 | 0.210 |
Why?
|
| Antigen Presentation | 1 | 2025 | 240 | 0.200 |
Why?
|
| Dermatitis | 1 | 2023 | 28 | 0.190 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 122 | 0.190 |
Why?
|
| Methotrexate | 1 | 2023 | 81 | 0.190 |
Why?
|
| Nanostructures | 1 | 2024 | 184 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 664 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 875 | 0.170 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 100 | 0.170 |
Why?
|
| Theranostic Nanomedicine | 1 | 2020 | 9 | 0.170 |
Why?
|
| Ligands | 2 | 2022 | 417 | 0.170 |
Why?
|
| Cytokines | 1 | 2024 | 955 | 0.160 |
Why?
|
| Humans | 7 | 2026 | 64959 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 43 | 0.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 40 | 0.150 |
Why?
|
| Microcirculation | 1 | 2019 | 59 | 0.150 |
Why?
|
| Drug Synergism | 1 | 2019 | 143 | 0.150 |
Why?
|
| Static Electricity | 2 | 2018 | 170 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2021 | 159 | 0.150 |
Why?
|
| Particle Size | 2 | 2018 | 428 | 0.140 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 214 | 0.140 |
Why?
|
| Boron Compounds | 1 | 2018 | 22 | 0.140 |
Why?
|
| Liposomes | 1 | 2018 | 116 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 317 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 357 | 0.130 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 280 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 128 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 305 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2016 | 159 | 0.110 |
Why?
|
| Female | 5 | 2025 | 33862 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1218 | 0.100 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2011 | 29 | 0.090 |
Why?
|
| Interferon Type I | 2 | 2024 | 196 | 0.080 |
Why?
|
| Ovalbumin | 1 | 2009 | 113 | 0.070 |
Why?
|
| Gels | 1 | 2009 | 77 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 1008 | 0.070 |
Why?
|
| Cytosol | 1 | 2009 | 185 | 0.070 |
Why?
|
| Influenza A virus | 1 | 2009 | 119 | 0.070 |
Why?
|
| DNA | 1 | 2011 | 849 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2024 | 121 | 0.050 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2023 | 13 | 0.050 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2023 | 26 | 0.050 |
Why?
|
| Peptidoglycan | 1 | 2023 | 55 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 970 | 0.050 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2022 | 4 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2022 | 19 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2022 | 39 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 222 | 0.040 |
Why?
|
| Porosity | 1 | 2021 | 41 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 52 | 0.040 |
Why?
|
| Nanomedicine | 1 | 2020 | 24 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2020 | 42 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 173 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2023 | 418 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2021 | 64 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 921 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 596 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2017 | 293 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1186 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 649 | 0.030 |
Why?
|
| Vaccines | 1 | 2017 | 96 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2024 | 3149 | 0.030 |
Why?
|
| Melanoma | 1 | 2017 | 332 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 510 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 206 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 285 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2009 | 176 | 0.020 |
Why?
|
| Endosomes | 1 | 2009 | 180 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 469 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 279 | 0.020 |
Why?
|
| Monocytes | 1 | 2009 | 363 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1298 | 0.010 |
Why?
|